About
Oxford Endovascular Ltd. is a medical technology company based in Oxford, United Kingdom. Founded in 2015 as a spin-out from Oxford University, the company specializes in developing innovative medical devices to prevent brain hemorrhages caused by intracranial aneurysms. Their flagship product, OXIFLOW™, is a next-generation flow-diverter designed for minimally invasive treatment. It safely diverts blood flow away from at-risk aneurysms, enhancing safety and efficacy compared to existing treatments. The company focuses on the Endovascular Cerebral Aneurysms Repair (ECAR) market, which is expected to grow significantly in the coming years. Oxford Endovascular is dedicated to research, development, and clinical validation of its technology, conducting early feasibility studies to gather essential data for regulatory approval. Their technology aims to benefit healthcare providers and patients at risk of brain hemorrhage due to aneurysms, a condition that affects approximately 1 in 50 people.
Technologies
Keywords
Company Information
- Employees12
- Founded2015
- Annual Revenue$1300000
- Total Funding$24457125
Location
West Way, Oxford, England, United Kingdom, OX2 0JJ